[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo
This study was the first to investigate the synthesis of near-infrared light-sensitive NO prodrug [Mn(PaPy2Q)(NO)]ClO4, and detection the amount of NO released by the drug in different time and near infrared light (10 mW, 20 mW). It showed that with the increase of light power, the time required for...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332221001736 |
id |
doaj-3741385dee6e479ebf79a4ab9a32e231 |
---|---|
record_format |
Article |
spelling |
doaj-3741385dee6e479ebf79a4ab9a32e2312021-07-15T04:26:53ZengElsevierBiomedicine & Pharmacotherapy0753-33222021-05-01137111388[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivoYuwan Zhao0Zhuo Li1Huancheng Tang2Shanhong Lin3Wenfeng Zeng4Dongcai Ye5Xin Zeng6Qiuming Luo7Jianwei Li8Zhixian Ao9Jierong Mo10Lixin Chen11Yiqiu Yang12Yunsheng Huang13Jianjun Liu14Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaLaboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, ChinaSchool of Pharmacy, Guangdong Medical University, Xincheng Ave, Songshan Lake Technology Park, Dongguan 523808, ChinaSchool of Pharmacy, Guangdong Medical University, Xincheng Ave, Songshan Lake Technology Park, Dongguan 523808, China; Corresponding authors.Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China; Corresponding authors.This study was the first to investigate the synthesis of near-infrared light-sensitive NO prodrug [Mn(PaPy2Q)(NO)]ClO4, and detection the amount of NO released by the drug in different time and near infrared light (10 mW, 20 mW). It showed that with the increase of light power, the time required for the drug to release NO was shortened, and we selected 20 mW, 10 min as a follow-up study of light power and irradiation time while ensuring the near-infrared light did not affect tumor cells. The cells were irradiated with 20 mW of near-infrared light for 10 min at 6 h after treatment with the drug on PC-3, LNCaP and 22RV1 cells, and NO concentration and cell survival rate were tested at 12 h, 24 h and 48 h. Experiments showed that NO concentration remained stable within 48 h and [Mn(PaPy2Q)(NO)]ClO4 inhibited the proliferation of cells in a concentration and time-dependent manner. Then we also found that [Mn(PaPy2Q)(NO)]ClO4 increased the expression of apoptosis-related proteins (PARP, Bax, Caspase 3/9), inhibited the expression of BCl-2 and increased the activity level of Caspase 3/7, which showed [Mn(PaPy2Q)(NO)]ClO4 promoted prostate cancer cells apoptosis. Next, the results in xenograft mouse model showed that [Mn(PaPy2Q)(NO)]ClO4 also had anti-prostate cancer effects in vivo, and the NO concentration increased in the tumor after near-infrared light irradiation. After [Mn(PaPy2Q)(NO)]ClO4 treatment 6 weeks, tumor volume was significantly reduced, Ki67 and BrdU protein expression was significantly reduced. TUNEL assay results showed that [Mn(PaPy2Q)(NO)]ClO4 could promote the apoptosis of solid tumors in vivo and in a concentration-dependent manner.http://www.sciencedirect.com/science/article/pii/S0753332221001736Prostate cancerNO prodrugNear-infrared light sensitiveNude mouse xenograft |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yuwan Zhao Zhuo Li Huancheng Tang Shanhong Lin Wenfeng Zeng Dongcai Ye Xin Zeng Qiuming Luo Jianwei Li Zhixian Ao Jierong Mo Lixin Chen Yiqiu Yang Yunsheng Huang Jianjun Liu |
spellingShingle |
Yuwan Zhao Zhuo Li Huancheng Tang Shanhong Lin Wenfeng Zeng Dongcai Ye Xin Zeng Qiuming Luo Jianwei Li Zhixian Ao Jierong Mo Lixin Chen Yiqiu Yang Yunsheng Huang Jianjun Liu [Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo Biomedicine & Pharmacotherapy Prostate cancer NO prodrug Near-infrared light sensitive Nude mouse xenograft |
author_facet |
Yuwan Zhao Zhuo Li Huancheng Tang Shanhong Lin Wenfeng Zeng Dongcai Ye Xin Zeng Qiuming Luo Jianwei Li Zhixian Ao Jierong Mo Lixin Chen Yiqiu Yang Yunsheng Huang Jianjun Liu |
author_sort |
Yuwan Zhao |
title |
[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo |
title_short |
[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo |
title_full |
[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo |
title_fullStr |
[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo |
title_full_unstemmed |
[Mn(PaPy2Q)(NO)]ClO4, a Near-Infrared Light activated release of Nitric Oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo |
title_sort |
[mn(papy2q)(no)]clo4, a near-infrared light activated release of nitric oxide drug as a nitric oxide donor for therapy of human prostate cancer cells in vitro and in vivo |
publisher |
Elsevier |
series |
Biomedicine & Pharmacotherapy |
issn |
0753-3322 |
publishDate |
2021-05-01 |
description |
This study was the first to investigate the synthesis of near-infrared light-sensitive NO prodrug [Mn(PaPy2Q)(NO)]ClO4, and detection the amount of NO released by the drug in different time and near infrared light (10 mW, 20 mW). It showed that with the increase of light power, the time required for the drug to release NO was shortened, and we selected 20 mW, 10 min as a follow-up study of light power and irradiation time while ensuring the near-infrared light did not affect tumor cells. The cells were irradiated with 20 mW of near-infrared light for 10 min at 6 h after treatment with the drug on PC-3, LNCaP and 22RV1 cells, and NO concentration and cell survival rate were tested at 12 h, 24 h and 48 h. Experiments showed that NO concentration remained stable within 48 h and [Mn(PaPy2Q)(NO)]ClO4 inhibited the proliferation of cells in a concentration and time-dependent manner. Then we also found that [Mn(PaPy2Q)(NO)]ClO4 increased the expression of apoptosis-related proteins (PARP, Bax, Caspase 3/9), inhibited the expression of BCl-2 and increased the activity level of Caspase 3/7, which showed [Mn(PaPy2Q)(NO)]ClO4 promoted prostate cancer cells apoptosis. Next, the results in xenograft mouse model showed that [Mn(PaPy2Q)(NO)]ClO4 also had anti-prostate cancer effects in vivo, and the NO concentration increased in the tumor after near-infrared light irradiation. After [Mn(PaPy2Q)(NO)]ClO4 treatment 6 weeks, tumor volume was significantly reduced, Ki67 and BrdU protein expression was significantly reduced. TUNEL assay results showed that [Mn(PaPy2Q)(NO)]ClO4 could promote the apoptosis of solid tumors in vivo and in a concentration-dependent manner. |
topic |
Prostate cancer NO prodrug Near-infrared light sensitive Nude mouse xenograft |
url |
http://www.sciencedirect.com/science/article/pii/S0753332221001736 |
work_keys_str_mv |
AT yuwanzhao mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT zhuoli mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT huanchengtang mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT shanhonglin mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT wenfengzeng mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT dongcaiye mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT xinzeng mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT qiumingluo mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT jianweili mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT zhixianao mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT jierongmo mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT lixinchen mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT yiqiuyang mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT yunshenghuang mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo AT jianjunliu mnpapy2qnoclo4anearinfraredlightactivatedreleaseofnitricoxidedrugasanitricoxidedonorfortherapyofhumanprostatecancercellsinvitroandinvivo |
_version_ |
1721301978109181952 |